Complete Genomics, Inc. (GNOM) Misses Q4 EPS by 2c

Complete Genomics, Inc. (NASDAQ: GNOM) reported Q4 EPS of ($0.67), $0.02 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $3.15 million.

Sees sequencing 1,100-1,300 genomes during Q1.

For earnings history and earnings-related data on Complete Genomics, Inc. (GNOM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Diana Shipping withdraws bid to acquire Genco Shipping
• Diana Shipping drops bid for Genco after price demands spike to $36.91